These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Electrophysiology and pharmacology of aprindine, encainide, and propafenone. Zipes DP, Prystowsky EN, Heger JJ. Ann N Y Acad Sci; 1984; 432():201-9. PubMed ID: 6441495 [No Abstract] [Full Text] [Related]
11. Flecainide and CAST. Lancet; 1989 Aug 26; 2(8661):481-2. PubMed ID: 2570188 [No Abstract] [Full Text] [Related]
12. Encainide: a useful new antiarrhythmic drug. Funck-Brentano C. Am J Med Sci; 1988 Jul 26; 296(1):76-7. PubMed ID: 3136649 [No Abstract] [Full Text] [Related]
13. Efficacy of encainide in supraventricular arrhythmias. Pool PE. Cardiovasc Drugs Ther; 1990 Jun 26; 4 Suppl 3():573-7. PubMed ID: 2125835 [Abstract] [Full Text] [Related]
14. An interim perspective on the removal of encainide and flecainide from the cardiac arrhythmia suppression trial. Coyle JD, Schaal SF. DICP; 1989 Jun 26; 23(6):478-9. PubMed ID: 2500783 [No Abstract] [Full Text] [Related]
15. Spectrum of antiarrhythmic response to encainide. Duff HJ, Roden DM, Carey EL, Wang T, Primm RK, Woosley RL. Am J Cardiol; 1985 Nov 15; 56(13):887-91. PubMed ID: 3933319 [Abstract] [Full Text] [Related]
18. Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure. Gottlieb SS, Kukin ML, Yushak M, Medina N, Packer M. Ann Intern Med; 1989 Apr 01; 110(7):505-9. PubMed ID: 2493762 [Abstract] [Full Text] [Related]